AstraZeneca Pharma India Limited (BOM:506820)

India · Delayed Price · Currency is INR

8,415.50

+125.65 (1.52%)

At close: Mar 25, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Healthcare	17.16B	12.96B	10.03B	8.06B	8.14B
Healthcare Growth	32.48%	29.17%	24.50%	-0.98%	-2.19%
Total	17.16B	12.96B	10.03B	8.06B	8.14B
Total Growth	32.48%	29.17%	24.50%	-0.98%	-2.19%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	16.07B	12.02B	9.39B	7.59B	7.79B
India Growth	33.67%	28.01%	23.68%	-2.59%	-2.51%
Outside India	1.10B	936.00M	640.50M	464.30M	341.70M
Outside India Growth	17.19%	46.14%	37.95%	35.88%	5.72%
Total	17.16B	12.96B	10.03B	8.06B	8.14B
Total Growth	32.48%	29.17%	24.50%	-0.98%	-2.19%

Source: S&P Global Market Intelligence.